Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 3.05 is 90% below its 1-year average of 30.85, near the low end of its 1-year range (3.05–84.61).
As of the fiscal period ended Wednesday, December 31, 2025. 90.13% below its 12-month average of 30.85.
Reported quarterly current ratio; no daily interpolation. Q4 FY2025 (2025-12-31): 3.05.
CURRENT RATIO
3.05
CURRENT RATIO AVG TTM
30.85
CURRENT RATIO AVG 3Y
N/A
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-90.13%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.66
median of 815 covered companies
CURRENT VS SECTOR MEDIAN
-16.80%
vs the sector median at left
Market Cap
$857.36M
Current Ratio
1.39
TTM Avg
1.36
3Y Avg
1.46
5Y Avg
2.28
Market Cap
$860.72M
Current Ratio
1.95
TTM Avg
2.27
3Y Avg
2.05
5Y Avg
2.13
Market Cap
$865.23M
Current Ratio
16.16
TTM Avg
3.88
3Y Avg
3.97
5Y Avg
4.50
Market Cap
$842.52M
Current Ratio
25.06
TTM Avg
12.67
3Y Avg
12.67
5Y Avg
12.67
Market Cap
$835.55M
Current Ratio
4.92
TTM Avg
7.19
3Y Avg
6.36
5Y Avg
8.34
Market Cap
$830.54M
Current Ratio
9.52
TTM Avg
4.26
3Y Avg
6.09
5Y Avg
7.80
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SL Science Holding Ltd (SLBT) | $857.63M | 3.05 | 30.85 | N/A | N/A |
| QuidelOrtho Corporation (QDEL)vs › | $857.36M | 1.39 | 1.36 | 1.46 | 2.28 |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $860.72M | 1.95 | 2.27 | 2.05 | 2.13 |
| SI-BONE, Inc. (SIBN)vs › | $862.50M | 9.15 | 8.11 | 7.93 | 9.72 |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $865.23M | 16.16 | 3.88 | 3.97 | 4.50 |
| SpyGlass Pharma, Inc. Common Stock (SGP)vs › | $842.52M | 25.06 | 12.67 | 12.67 | 12.67 |
| Pacific Biosciences of California, Inc. (PACB)vs › | $835.55M | 4.92 | 7.19 | 6.36 | 8.34 |
| Alumis Inc. (ALMS)vs › | $834.31M | 6.74 | 5.17 | 5.15 | 5.15 |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $830.54M | 9.52 | 4.26 | 6.09 | 7.80 |
| Arbutus Biopharma Corp (ABUS)vs › | $881.22M | 81.42 | 11.94 | 8.59 | 10.34 |
Current Ratio
3.05
Quick Ratio
3.05
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2025-12-31 | 3.05 |
| 2025-06-30 | 4.90 |
| 2024-12-31 | 84.61 |
